Recessive congenital methemoglobinemia type II: Hypoplastic basal ganglia in two siblings with a novel mutation of the cytochrome b5 reductase gene
- 7 January 2019
- journal article
- case report
- Published by SAGE Publications in The Neuroradiology Journal
- Vol. 32 (2) , 143-147
Abstract
Recessive congenital methemoglobinemia type II is a very rare autosomal recessive hematologic disorder due to NADH-cytochrome b5 reductase deficiency, usually caused by full-stop mutations or deletions. This disease classically presents with mild neonatal cyanosis, early onset severe progressive developmental delay, movement disorders, and progressive microcephaly. We report two siblings with recessive congenital methemoglobinemia type II whose evaluation revealed a novel p.Arg92Trp missense mutation of the CYB5R3 gene and a peculiar imaging finding of basal ganglia hypoplasia. Brain magnetic resonance imaging was performed at age 10 months in the older sibling and at age three months in the younger sibling. It revealed similar findings of bilateral small size of the lentiform and caudate nuclei and reduced frontotemporal brain volume. Our patient cases highlight that basal ganglia hypoplasia is an interesting clue to the very rare and frequently unsuspected diagnosis of recessive congenital methemoglobinemia type II, that may explain the associated movement disorders. The novel missense mutation is one of very few identified missense mutations known to cause severe type II recessive congenital methemoglobinemia.Keywords
This publication has 15 references indexed in Scilit:
- Congenital Methemoglobinemia Type II-Clinical Improvement with Short-Term Methylene Blue TreatmentPediatric Blood & Cancer, 2015
- Normal MyelinationNeuroimaging Clinics Of North America, 2013
- Cerebellar atrophy in a child with hereditary methemoglobinemia type IIBrain and Development, 2011
- 1H MR spectroscopy in pediatricsEuropean Journal of Radiology, 2008
- Recessive hereditary methaemoglobinaemia, type II: delineation of the clinical spectrumBrain, 2008
- Heterogeneity of the molecular biology of methemoglobinemia: a study of eight consecutive patients.2005
- Severe neurological impairment in hereditary methaemoglobinaemia type 2European Journal of Pediatrics, 2004
- Seven new mutations in the nicotinamide adenine dinucleotide reduced–cytochrome b5 reductase gene leading to methemoglobinemia type IBlood, 2001
- Participation of a cytochrome b5-like hemoprotein of outer mitochondrial membrane (OM cytochrome b) in NADH-semidehydroascorbic acid reductase activity of rat liverBiochemical and Biophysical Research Communications, 1981
- Lipids of myelin, white matter and gray matter in a case of generalized deficiency of cytochrome b5 reductase in congenital methemoglobinemia with mental retardationLipids, 1980